| Entry |
|
|---|
| Name |
Camostat (INN) |
|---|
| Formula |
C20H22N4O5
|
|---|
| Exact mass |
398.159
|
|---|
| Mol weight |
398.4125
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00165): | D01766<JP> |
|
|---|
| Efficacy |
Anti-inflammatory, Serine protease inhibitor |
|---|
| Target |
serine proteases |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AB Proteinase inhibitors
B02AB04 Camostat
D07606 Camostat (INN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02012 Antifibrinolytic
DG01990 Serine protease inhibitor
DG00165 Camostat
D07606 Camostat
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02012 Antifibrinolytic
DG01990 Serine protease inhibitor
DG00165 Camostat
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 29
1 C8y C 19.9500 -16.8700
2 C8x C 19.9500 -15.4700
3 C8x C 18.7600 -14.7700
4 C8y C 17.5000 -15.4700
5 C8x C 17.5000 -16.8700
6 C8x C 18.6900 -17.5700
7 N1b N 16.3100 -14.7700
8 C2c C 15.1200 -15.4700
9 N2a N 13.8600 -14.7700
10 N1a N 15.1200 -16.8700
11 C7a C 21.1400 -17.5700
12 O7a O 22.3300 -16.8700
13 C8y C 23.5900 -17.5700
14 O6a O 21.1400 -18.9700
15 C8x C 24.7800 -16.8700
16 C8x C 25.9700 -17.5700
17 C8y C 25.9700 -18.9700
18 C8x C 24.7800 -19.6700
19 C8x C 23.5900 -18.9700
20 C1b C 27.2300 -19.6700
21 C7a C 28.4200 -18.9700
22 O7a O 29.6100 -19.6700
23 C1b C 30.8700 -18.9700
24 C5a C 32.0600 -19.6700
25 N1c N 33.2500 -18.9700
26 C1a C 34.4400 -19.6700
27 O6a O 28.4200 -17.5700
28 O5a O 32.0600 -21.0700
29 C1a C 33.2500 -17.5700
BOND 30
1 1 2 2
2 13 15 2
3 15 16 1
4 16 17 2
5 17 18 1
6 18 19 2
7 19 13 1
8 8 9 2
9 17 20 1
10 2 3 1
11 20 21 1
12 8 10 1
13 21 22 1
14 3 4 2
15 22 23 1
16 1 11 1
17 23 24 1
18 4 5 1
19 24 25 1
20 11 12 1
21 25 26 1
22 5 6 2
23 21 27 2
24 12 13 1
25 24 28 2
26 6 1 1
27 25 29 1
28 11 14 2
29 4 7 1
30 7 8 1
|
|---|
